Search Results - "Hu, Qingzhong"

Refine Results
  1. 1

    Cushing’s Syndrome: Development of Highly Potent and Selective CYP11B1 Inhibitors of the (Pyridylmethyl)pyridine Type by Emmerich, Juliette, Hu, Qingzhong, Hanke, Nina, Hartmann, Rolf W

    Published in Journal of medicinal chemistry (08-08-2013)
    “…Potent and selective CYP11B1 inhibitors could be promising therapeutics for the treatment of Cushing’s syndrome. Optimization of Ref 1…”
    Get full text
    Journal Article
  2. 2

    3-Pyridyl substituted aliphatic cycles as CYP11B2 inhibitors: aromaticity abolishment of the core significantly increased selectivity over CYP1A2 by Yin, Lina, Hu, Qingzhong, Hartmann, Rolf W

    Published in PloS one (01-11-2012)
    “…Aldosterone synthase (CYP11B2) is a promising therapeutic target for the treatment of cardiovascular diseases related to abnormally high aldosterone levels. On…”
    Get full text
    Journal Article
  3. 3

    Recent progress in pharmaceutical therapies for castration-resistant prostate cancer by Yin, Lina, Hu, Qingzhong, Hartmann, Rolf W

    “…Since 2010, six drugs have been approved for the treatment of castration-resistant prostate cancer, i.e., CYP17 inhibitor Abiraterone, androgen receptor…”
    Get full text
    Journal Article Book Review
  4. 4

    Highly Potent and Selective Nonsteroidal Dual Inhibitors of CYP17/CYP11B2 for the Treatment of Prostate Cancer To Reduce Risks of Cardiovascular Diseases by Pinto-Bazurco Mendieta, Mariano A. E, Hu, Qingzhong, Engel, Matthias, Hartmann, Rolf W

    Published in Journal of medicinal chemistry (08-08-2013)
    “…Dual CYP17/CYP11B2 inhibitors are proposed as a novel strategy for the treatment of prostate cancer to reduce risks of cardiovascular diseases. Via a…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Manipulations of phenylnorbornyl palladium species for multicomponent construction of a bridged polycyclic privileged scaffold by Yin, Lina, Guan, Ting, Cheng, Jie, Pan, Dongchao, Lu, Jinyang, Huang, Jiahui, Wu, Jiaqi, Chen, Xiaoli, You, Taiyun, Huo, Xuting, He, Yuting, Pang, Jiayun, Hu, Qingzhong

    Published in Communications chemistry (29-10-2022)
    “…Hexahydromethanocarbazole is a privileged scaffold in the discovery of new drugs and photoactive organic materials due to its good balance between structural…”
    Get full text
    Journal Article
  7. 7

    CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents by Yin, Lina, Hu, Qingzhong

    Published in Nature reviews. Urology (01-01-2014)
    “…Key Points 17α-Hydroxylase/C17,20-lyase (CYP17) is a steroidogenic enzyme that is central to the production of androgens, and is targeted by abiraterone in men…”
    Get full text
    Journal Article
  8. 8

    Chimera induced protein degradation: PROTACs and beyond by Yin, Lina, Hu, Qingzhong

    Published in European journal of medicinal chemistry (15-11-2020)
    “…Ubiquitin–proteasome system, autophagy-lysosome pathway and N-end rule pathway are crucial protein quality control mechanisms in human body. Hijacking these…”
    Get full text
    Journal Article
  9. 9

    Visible-Light-Promoted [4π + 2σ] Annulation of Dienes and Alkylamines via Dual Inert C(sp3)–H Bond Activation by Wang, Shuzhong, Zheng, Nuowen, Deji, Cuo, Hu, Qingzhong, Wu, Xinxin, Zhan, Ruoting, Huang, Huicai, Zhang, Yue

    Published in Organic letters (23-05-2024)
    “…Herein, visible-light-promoted [4π + 2σ] annulation of dienes and alkylamines was achieved via dual C­(sp3)–H bond functionalization of alkylamines. The…”
    Get full text
    Journal Article
  10. 10

    Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitis by Li, Haiyan, Guan, Ting, Qin, Shi, Xu, Qihao, Yin, Lina, Hu, Qingzhong

    Published in Drug discovery today (01-03-2023)
    “…•Many natural products ameliorate nonalcoholic fatty liver disease and nonalcoholic steatohepatitis via various mechanisms.•Alkaloids and terpenoids deserve…”
    Get full text
    Journal Article
  11. 11

    Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases by Hu, Qingzhong, Yin, Lina, Hartmann, Rolf W

    Published in Journal of medicinal chemistry (26-06-2014)
    “…Besides the well-known roles of aldosterone as a mineralocorticoid in regulating homeostasis of electrolytes and volume, recent studies revealed that it is…”
    Get full text
    Journal Article
  12. 12

    Design, Synthesis, and Biological Evaluations of Pyridyl 4,5,6,7-Tetrahydro-4,7-Methanobenzo[d]isoxazoles as Potent and Selective Inhibitors of 11β-Hydroxylase by Yin, Lina, Pan, Youtian, Xue, Yuanyuan, Chen, Xiaoli, You, Taiyun, Huang, Jiahui, Xu, Qihao, Hu, Qingzhong

    Published in Journal of medicinal chemistry (08-09-2022)
    “…Inhibition of CYP11B1 is a promising therapy for severe diseases caused by excessive cortisol. Enantiomer discrimination provides clues to achieve selectivity…”
    Get full text
    Journal Article
  13. 13

    Tetrahydropyrroloquinolinone Type Dual Inhibitors of Aromatase/Aldosterone Synthase as a Novel Strategy for Breast Cancer Patients with Elevated Cardiovascular Risks by Yin, Lina, Hu, Qingzhong, Hartmann, Rolf W

    Published in Journal of medicinal chemistry (24-01-2013)
    “…The application of aromatase inhibitors to postmenopausal breast cancer patients increases the risk of cardiovascular diseases (CVD), which is believed to be…”
    Get full text
    Journal Article
  14. 14

    Selective Dual Inhibitors of CYP19 and CYP11B2: Targeting Cardiovascular Diseases Hiding in the Shadow of Breast Cancer by Hu, Qingzhong, Yin, Lina, Hartmann, Rolf W

    Published in Journal of medicinal chemistry (23-08-2012)
    “…Postmenopausal women are at high risk for cardiovascular diseases because of the estrogen deficiency. As for postmenopausal breast cancer patients, this risk…”
    Get full text
    Journal Article
  15. 15

    Proposing anti‐counterfeiting pharmacopoeia quality markers for Shenlingbaizhu granule based on UHPLC‐Q‐orbitrap‐MS identification by Zeng, Jingyuan, Li, Xican, Cai, Rongxin, Chen, Ban, Li, Chunhou, Hu, Qingzhong, Sun, Yue

    Published in Phytochemical analysis (01-03-2024)
    “…Introduction Shenlingbaizhu granule, a Traditional Chinese Medicine prescription comprising Renshen, Gancao, and Shanyao, is widely consumed in China nowadays…”
    Get full text
    Journal Article
  16. 16

    Sinomenine Derivatives: Synthesis, Antitumor Activity, and Apoptotic Induction in MCF‐7 Cells via IL‐6/PI3K/Akt/NF‐κB Signaling Pathway by Zhu, Zuchang, Zhou, Huixian, Chen, Fenglian, Deng, Jianxiong, Yin, Lina, He, Baoen, Hu, Qingzhong, Wang, Tao

    Published in ChemMedChem (19-07-2022)
    “…Natural products have been widely considered as an important resource for new drugs or lead compounds. Sinomenine (SIN) and its derivatives exert antitumor…”
    Get full text
    Journal Article
  17. 17

    Fluorescence detecting glycopeptide antibiotics via a dynamic molecular switch by Zou, Xiaomei, Lin, Yanting, Zhang, Shihui, Deng, Tao, Xu, Ximing, Zhou, Yingchun, Liu, Zhihui, Lu, Weiguo, Hu, Qingzhong, Lin, Chaozhan, Zhu, Chenchen, Liu, Fang

    Published in Analytica chimica acta (15-03-2024)
    “…Glycopeptide antibiotics (GPAs) represented by vancomycin (VAN) are clinically used as a first-line treatment for serious infections caused by Gram-positive…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Therapeutic compounds for Cushing's syndrome: a patent review (2012-2016) by Ma, Li, Yin, Lina, Hu, Qingzhong

    Published in Expert opinion on therapeutic patents (01-11-2016)
    “…Endogenous Cushing's syndrome (CS) is a set of disorders caused by chronic exposure to excess glucocorticoids induced by neuroendocrine tumors in pituitary,…”
    Get more information
    Journal Article
  20. 20

    Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis by Gobbi, Silvia, Hu, Qingzhong, Zimmer, Christina, Engel, Matthias, Belluti, Federica, Rampa, Angela, Hartmann, Rolf W, Bisi, Alessandra

    Published in Journal of medicinal chemistry (24-03-2016)
    “…The inhibition of corticosteroid biosynthesis could be considered as an emerging strategy to reduce their abnormally high levels, and in this framework CYP11B1…”
    Get full text
    Journal Article